Clinical Trial Results:
International Phase II Studies of
131I-mIBG in combination with topotecan
and peripheral blood stem cell rescue for
(A) primary resistant high risk neuroblastoma and
(B) relapsed stage 4 neuroblastoma
Summary
|
|
EudraCT number |
2005-002089-13 |
Trial protocol |
GB |
Global completion date |
31 Dec 2004
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Jun 2019
|
First version publication date |
07 Jun 2019
|
Other versions |
|
Summary report(s) |
Publication |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.